Weekly Cisplatin plus Capecitabine is an active regimen in heavily pretreated advanced breast cancer patients

被引：0
|
作者：
Donadio, Michela [1 ]
Beano, Alessandra [1 ]
Ardine, Mara [1 ]
Bonardi, Simone [2 ]
Mistrangelo, Marinella [1 ]
Polimeni, Maria A. [1 ]
Castiglione, Federico [3 ]
Forti, Laura [4 ]
Bottini, Alberto [2 ]
Bertetto, Oscar [1 ]
机构：
[1] Azienda Osped San Giovanni Battista, COES, Turin, Italy
[2] Azienda Osped Ist Ospetalieri, Cremona, Italy
[3] Osped San Lazzaro, Alba, Italy
[4] Osped Maggiore La Carita, SCDU Oncol Med, Novara, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [1] Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes
    Donadio, M
    Ardine, M
    Berruti, A
    Beano, A
    Bottini, A
    Mistrangelo, M
    Bonardi, S
    Castiglione, F
    Generali, D
    Polimeni, MA
    Bretti, S
    Alabiso, O
    Bertetto, O
    ONCOLOGY, 2005, 69 (05) : 408 - 413
  • [2] CISPLATIN AND CAPECITABINE IN HEAVILY PRETREATED ADVANCED BREAST CANCER DISEASE: A PHASE II STUDY
    Donadio, Michela
    Beano, Alessandra
    Ardine, Mara
    Mistrangelo, Marinella
    Bonardi, Simone
    Castiglione, Federico
    Polimeni, Maria Antonia
    Forti, Laura
    Bottini, Alberto
    Bertetto, Oscar
    ANNALS OF ONCOLOGY, 2004, 15 : 18 - 18
  • [3] Gemcitabine plus cisplatin patients with heavily pretreated advanced breast cancer with brain metastases.
    Gorbunova, V. A.
    Bychkov, M. B.
    Naskhletashvili, D. R.
    Chmutin, G. E.
    Karahan, V. B.
    Aloshin, V. A.
    Moskvina, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Trastuzumab (T) plus capecitabine (C) in heavily pretreated patients (pts) with advanced breast cancer (ABC)
    Bartsch, R.
    Wenzel, C.
    Altorjai, G.
    Pluschnig, U.
    Locker, G. J.
    Rudas, M.
    Mader, R. M.
    Zielinski, C. C.
    Steger, G. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Cisplatin plus epirubicin plus paclitaxel weekly regimen in advanced breast cancer: A phase I study
    Frasci, G
    Manzione, L
    Comella, P
    D'Aiuto, G
    Capasso, I
    Carteni, G
    Thomas, R
    Pacilio, C
    Apicella, A
    Gravina, A
    Guida, T
    Di Bonito, M
    Piccolo, S
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 15 - 16
  • [6] Lapatinib plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Watanabe, J.
    Hamauchi, S.
    Higashi, Y.
    Onozawa, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience
    de Lima Araujo, Luiz Henrique
    Moitinho, Marcos Veloso
    Fantini Silva, Ana Maria
    Sousa Gomes, Cleudes Alice
    Noronha, Helio, Jr.
    MEDICAL ONCOLOGY, 2011, 28 : S2 - S7
  • [8] Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience
    Luiz Henrique de Lima Araújo
    Marcos Veloso Moitinho
    Ana Maria Fantini Silva
    Cleudes Alice Sousa Gomes
    Hélio Noronha Júnior
    Medical Oncology, 2011, 28 : 2 - 7
  • [9] Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Altorjai, Gabriela
    Pluschnig, Ursula
    Rudas, Margaretha
    Mader, Robert M.
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3853 - 3858
  • [10] Folfox 2 regimen in heavily pretreated patients with advanced colorectal cancer
    Luppi, G
    Zanelli, F
    Di Stasi, A
    Bertolini, F
    Pifferi, M
    TUMORI JOURNAL, 2002, 88 (04): : 270 - 272
12345